Pandora Still a Strong Outperform and 4 Analyst Notes to Know

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR): Current price $11.99

Baird believes Optimer Pharmaceuticals, Inc. remains an attractive investment and estimates a buyer can get a deal done for under $1 billion in cash. The firm noted the departure of the Chief Executive Officer and General Counsel, due to potential compliance issues, related to a share grant at one of their Taiwanese subsidiaries. Baird said it is impossible to quantify the value of the liability at this point, but expects it to be a point of leverage for a suitor, rather than a deal breaker. Shares are Outperform rated with a $16 price target.

The stock market is roaring back in 2013. Click here now to discover winning stocks!

optr

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business